• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油三酯-葡萄糖相关标志物与代谢相关脂肪性肝病风险的相关性:一项在中国健康参与者中的横断面研究。

Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants.

机构信息

Health Management Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

Health Management Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

出版信息

BMJ Open. 2023 May 2;13(5):e070189. doi: 10.1136/bmjopen-2022-070189.

DOI:10.1136/bmjopen-2022-070189
PMID:37130686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10163481/
Abstract

OBJECTIVES

This study aimed to evaluate the performance of the triglyceride glucose (TyG) index and its related markers in predicting metabolic-associated fatty liver disease (MAFLD) in healthy Chinese participants.

DESIGN

This was a cross-sectional study.

SETTING

The study was conducted at Health Management Department of the Affiliated Hospital of Xuzhou Medical University.

PARTICIPANTS

A total of 20 922 asymptomatic Chinese participants (56% men) were enrolled.

OUTCOME MEASURES

Hepatic ultrasonography was performed to diagnose MAFLD based on the latest diagnostic criteria. The TyG, TyG-body mass (TyG-BMI) and TyG-waist circumference indices were calculated and analysed.

RESULTS

Compared with the lowest quartile of the TyG-BMI, the adjusted ORs and 95% CIs for MAFLD were 20.76 (14.54 to 29.65), 92.33 (64.61 to 131.95) and 380.87 (263.25 to 551.05) in the second, third and fourth quartiles, respectively. According to the subgroup analysis, the TyG-BMI in the female and the lean groups (BMI<23 kg/m) showed the strongest predictive value, with optimal cut-off values for MAFLD of 162.05 and 156.31, respectively. The areas under the receiver operating characteristic curves in female and lean groups were 0.933 (95% CI 0.927 to 0.938) and 0.928 (95% CI 0.914 to 0.943), respectively, with 90.7% sensitivity and 81.2% specificity in female participants with MAFLD and 87.2% sensitivity and 87.1% specificity in lean participants with MAFLD. The TyG-BMI index demonstrated superior predictive ability for MAFLD compared with other markers.

CONCLUSIONS

The TyG-BMI is an effective, simple and promising tool for predicting MAFLD, especially in lean and female participants.

摘要

目的

本研究旨在评估甘油三酯-葡萄糖(TyG)指数及其相关标志物在预测中国健康体检人群代谢相关脂肪性肝病(MAFLD)中的作用。

设计

这是一项横断面研究。

地点

研究在徐州医科大学附属医院健康管理部进行。

参与者

共纳入 20922 名无症状的中国参与者(56%为男性)。

结局测量

采用肝脏超声诊断 MAFLD,诊断标准采用最新标准。计算并分析 TyG、TyG-体重指数(TyG-BMI)和 TyG-腰围指数。

结果

与 TyG-BMI 最低四分位相比,TyG-BMI 第二、三、四分位的 MAFLD 校正比值比(OR)和 95%置信区间(CI)分别为 20.76(14.5429.65)、92.33(64.61131.95)和 380.87(263.25551.05)。根据亚组分析,女性和消瘦人群(BMI<23 kg/m)中 TyG-BMI 具有最强的预测价值,MAFLD 的最佳截断值分别为 162.05 和 156.31。女性和消瘦人群 TyG-BMI 的受试者工作特征曲线下面积分别为 0.933(95%CI 0.9270.938)和 0.928(95%CI 0.914~0.943),女性 MAFLD 患者的敏感度和特异度分别为 90.7%和 81.2%,消瘦 MAFLD 患者的敏感度和特异度分别为 87.2%和 87.1%。与其他标志物相比,TyG-BMI 对 MAFLD 具有更好的预测能力。

结论

TyG-BMI 是预测 MAFLD 的一种有效、简单且有前景的工具,尤其适用于消瘦和女性人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/cc52429bd274/bmjopen-2022-070189f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/d07820d86de5/bmjopen-2022-070189f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/2c867c2f6a9f/bmjopen-2022-070189f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/7cb6eed9fca3/bmjopen-2022-070189f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/f82c10568d6d/bmjopen-2022-070189f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/cc52429bd274/bmjopen-2022-070189f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/d07820d86de5/bmjopen-2022-070189f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/2c867c2f6a9f/bmjopen-2022-070189f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/7cb6eed9fca3/bmjopen-2022-070189f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/f82c10568d6d/bmjopen-2022-070189f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e71/10163481/cc52429bd274/bmjopen-2022-070189f05.jpg

相似文献

1
Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants.甘油三酯-葡萄糖相关标志物与代谢相关脂肪性肝病风险的相关性:一项在中国健康参与者中的横断面研究。
BMJ Open. 2023 May 2;13(5):e070189. doi: 10.1136/bmjopen-2022-070189.
2
Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease.肥胖和超重伴代谢相关脂肪性肝病儿童的胰岛素抵抗的生化和人体测量学指标。
Med Sci Monit. 2024 Jul 3;30:e943375. doi: 10.12659/MSM.943375.
3
Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study.中国人代谢相关脂肪性肝病中甘油三酯-葡萄糖指数及相关参数的诊断价值:一项横断面研究。
BMJ Open. 2023 Sep 29;13(9):e075413. doi: 10.1136/bmjopen-2023-075413.
4
Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.胰岛素抵抗指数对代谢功能障碍相关脂肪性肝病的诊断效能
Metab Syndr Relat Disord. 2024 Jun;22(5):402-409. doi: 10.1089/met.2023.0276. Epub 2024 Apr 4.
5
Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.改良的甘油三酯-葡萄糖指数是预测代谢功能障碍相关脂肪性肝病风险的可靠标志物:一项横断面研究。
Front Endocrinol (Lausanne). 2024 Jan 22;14:1308265. doi: 10.3389/fendo.2023.1308265. eCollection 2023.
6
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.非酒精性脂肪性肝病/代谢相关脂肪性肝病和肝纤维化的早期诊断潜在筛查指标:甘油三酯葡萄糖指数相关参数。
Front Endocrinol (Lausanne). 2022 Sep 2;13:951689. doi: 10.3389/fendo.2022.951689. eCollection 2022.
7
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.甘油三酯与葡萄糖指数(TyG)是识别非酒精性脂肪性肝病的有效生物标志物。
Lipids Health Dis. 2017 Jan 19;16(1):15. doi: 10.1186/s12944-017-0409-6.
8
The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.甘油三酯-葡萄糖-腰围与代谢相关脂肪性肝病及其严重程度的相关性:一项基于人群的美国成年人研究。
Scand J Gastroenterol. 2024 May;59(5):561-569. doi: 10.1080/00365521.2024.2305268. Epub 2024 Jan 18.
9
Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.体检指标在预测非肥胖人群脂肪肝中的应用。
Intern Med. 2023 Aug 15;62(16):2307-2319. doi: 10.2169/internalmedicine.1097-22. Epub 2022 Dec 14.
10
Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease.评估人体测量学指标的适当截断点及其与心血管代谢指标的关系,以预测代谢相关脂肪性肝病的风险。
BMC Endocr Disord. 2024 Jun 4;24(1):79. doi: 10.1186/s12902-024-01615-3.

引用本文的文献

1
Relationship between triglyceride and glucose related indexes and MAFLD in rural populations of northwest China.中国西北地区农村人群中甘油三酯及血糖相关指标与代谢相关脂肪性肝病的关系
Sci Rep. 2025 Aug 20;15(1):30665. doi: 10.1038/s41598-025-12658-4.
2
Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.甘油三酯葡萄糖-体质指数(TyG-BMI)与代谢功能障碍相关脂肪性肝病的关联:一项系统评价和荟萃分析
PLoS One. 2025 Aug 4;20(8):e0324483. doi: 10.1371/journal.pone.0324483. eCollection 2025.
3
TyG-BMI as a superior predictor of MAFLD and pre-MAFLD in Chinese adults: a cross-sectional study.

本文引用的文献

1
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.非酒精性脂肪性肝病/代谢相关脂肪性肝病和肝纤维化的早期诊断潜在筛查指标:甘油三酯葡萄糖指数相关参数。
Front Endocrinol (Lausanne). 2022 Sep 2;13:951689. doi: 10.3389/fendo.2022.951689. eCollection 2022.
2
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.甘油三酯-葡萄糖指数与甘油三酯/高密度脂蛋白胆固醇比值在代谢相关脂肪性肝病患者中的诊断价值比较:一项回顾性横断面研究。
Lipids Health Dis. 2022 Jun 25;21(1):55. doi: 10.1186/s12944-022-01661-7.
3
TyG-BMI作为中国成年人MAFLD和MAFLD前期的更优预测指标:一项横断面研究
BMC Gastroenterol. 2025 Jul 1;25(1):495. doi: 10.1186/s12876-025-04087-4.
4
Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis.甘油三酯、血糖、腰围与非酒精性脂肪性肝病:一项系统评价与荟萃分析
BMC Gastroenterol. 2025 May 1;25(1):328. doi: 10.1186/s12876-025-03888-x.
5
Predictive value of the triglyceride-glucose index for coronary artery bypass grafting-acute kidney injury patients.甘油三酯-葡萄糖指数对冠状动脉旁路移植术-急性肾损伤患者的预测价值。
BMC Cardiovasc Disord. 2025 Mar 21;25(1):206. doi: 10.1186/s12872-025-04584-0.
6
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
7
Relationship between TyG-related index and hearing loss in people over 45 s in China.中国45岁以上人群中TyG相关指数与听力损失的关系。
Front Public Health. 2025 Feb 5;13:1506368. doi: 10.3389/fpubh.2025.1506368. eCollection 2025.
8
Correlation analysis of the triglyceride-glucose index and related parameters in metabolic dysfunction-associated fatty liver disease.代谢功能障碍相关脂肪性肝病中甘油三酯-葡萄糖指数与相关参数的相关性分析
Sci Rep. 2025 Jan 2;15(1):23. doi: 10.1038/s41598-024-84809-y.
9
The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes.胰岛素抵抗指数预测2型糖尿病患者非酒精性脂肪性肝病的潜力。
BMC Endocr Disord. 2024 Dec 4;24(1):261. doi: 10.1186/s12902-024-01794-z.
10
Metabolic dysfunction associated fatty liver disease in healthy weight individuals.代谢功能障碍相关的健康体重个体的脂肪肝疾病。
Hepatol Int. 2024 Oct;18(Suppl 2):884-896. doi: 10.1007/s12072-024-10662-w. Epub 2024 Jul 25.
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.代谢(功能)相关正常体重型脂肪性肝病。
Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):638-651. doi: 10.1038/s41575-022-00635-5. Epub 2022 Jun 16.
4
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.甘油三酯-葡萄糖指数作为代谢相关脂肪性肝病(MAFLD)的临床有用标志物:一项针对伊朗成年人的基于人群的研究。
J Diabetes Metab Disord. 2022 Jan 11;21(1):97-107. doi: 10.1007/s40200-021-00941-w. eCollection 2022 Jun.
5
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.肥胖的病理生理分子机制:MAFLD 和 NASH 与心血管疾病的联系。
Int J Mol Sci. 2021 Oct 27;22(21):11629. doi: 10.3390/ijms222111629.
6
Estrogens and the regulation of glucose metabolism.雌激素与葡萄糖代谢的调节
World J Diabetes. 2021 Oct 15;12(10):1622-1654. doi: 10.4239/wjd.v12.i10.1622.
7
Comparison of Body Mass Index and Waist Circumference in the Prediction of Diabetes: A Retrospective Longitudinal Study.体重指数与腰围在糖尿病预测中的比较:一项回顾性纵向研究
Diabetes Ther. 2021 Oct;12(10):2663-2676. doi: 10.1007/s13300-021-01138-3. Epub 2021 Aug 26.
8
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.代谢相关脂肪性肝病与全因死亡率增加相关在美国。
J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8.
9
Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.基因组分析在非酒精性脂肪性肝病瘦型个体临床评估中的新作用。
Hepatology. 2021 Oct;74(4):2241-2250. doi: 10.1002/hep.32047.
10
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.中国城市人群代谢相关脂肪性肝病的流行情况及其危险因素:一项横断面对比研究。
BMC Gastroenterol. 2021 May 10;21(1):212. doi: 10.1186/s12876-021-01782-w.